4basebio PLC Registered Shares EO 1
Sector and Industry
Healthcare, Healthcare Services
Performance (1Y)
48.60%
Market Cap
85.17 Mil.
P/E Ratio
0.00
Dividend Yield
0.00 %
Earnings per Share
-1.27 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| UnitedHealth Group Inc. | 254.66 Bil. | 396.73 Bil. | 24.94 | -19.75 % | 0.00 | - |
| Thermo Fisher Scientific Inc. | 185.62 Bil. | 39.50 Bil. | 32.67 | +1.45 % | 0.00 | - |
| Danaher Corp. | 137.79 Bil. | 21.78 Bil. | 45.36 | -11.47 % | 0.00 | - |
| McKesson Corporation | 90.13 Bil. | 348.09 Bil. | 22.55 | +33.83 % | 0.00 | - |
| HCA Healthcare Inc. | 89.28 Bil. | 67.01 Bil. | 16.48 | +12.93 % | 0.00 | - |
| Elevance Health Inc. | 65.88 Bil. | 176.51 Bil. | 13.91 | -9.22 % | 0.00 | - |
| The Cigna Group | 61.74 Bil. | 243.65 Bil. | 12.41 | +66.33 % | 0.00 | - |
| Cencora Inc. | 51.58 Bil. | 291.15 Bil. | 39.26 | +1.16 % | 0.00 | - |
| IDEXX Laboratories Inc. | 45.92 Bil. | 3.81 Bil. | 51.74 | +14.41 % | 0.00 | - |
| Zoetis Inc. | 45.52 Bil. | 8.39 Bil. | 20.89 | +3.10 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 5.5 G | 0 Units |
| PRICE DETERMINATION TIME | 06/19/2026 / 12:18:04 PM | |
| DAILY VOLUME (UNITS) | 0 | |
| DAILY HIGH / LOW | 5.5 | 5.5 |
| PREV. DAY'S PRICE | 5.5 | (06/18) |
| CHANGE DAY BEFORE | +0.00 | 0.00 % |
| 52 WEEK HIGH / LOW | 11.4 (06/24) | 4.48 (05/18) |
Key Figures (in EUR)
| 2027 | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | - | -1.16 | -1.27 | -1.11 | -0.72 |
| DIVIDENDS PER SHARE | - | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | - | - | - | - | - |
| PRICE - BOOK RATIO | - | - | 9.45 | 7.10 | - |
| PRICE - SALES RATIO | - | - | 56.35 | 170.11 | 165.56 |
| PRICE - CASH FLOW RATIO | - | - | - | - | - |
Master Data
| WKN | A3CWA4 |
| ISIN | GB00BMCLYF79 |
| SYMBOL | 88Q |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | 4BASEBIO PLC EO 1 |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | British Pound Sterling |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Services |
| NUMBER OF SHARES | 15.48 Mil. |
| MARKET CAPITALISATION | 85.17 Mil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | 0.00 % | 13.64 % | -6.78 % | -17.29 % | -48.60 % | -14.73 % | 30.95 % | -21.43 % |
| HIGH | 5.50 | 6.40 | 6.40 | 7.00 | 11.40 | 20.00 | 20.00 | 7.00 |
| LOW | 5.50 | 4.48 | 4.48 | 4.48 | 4.48 | 4.48 | 4.00 | 4.48 |
Dividend
per share
4BASEBIO PLC EO 1 does not deliver dividend information
Company profile
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.